Search By Initial

Name Index M

• ML-264 (Catalog# : 17030302, Cas# : 1550008-55-3)ML-264 is a Krppel-like factor 5 (KLF5) inhibitor That Potently Inhibits Growth of Co
• MK-8245 (Catalog# : 17030109, Cas# : 1030612-90-8)MK-8245 is a potent, liver-targeted SCD inhibitor with preclinical antidiabetic and a
• MLN-1117 (Catalog# : 17030101, Cas# : 1268454-23-4)Serabelisib (also known as MLN1117, INK1117, and TAK-117) is an orally bioavailable i
• ML-281 (Catalog# : 17022811, Cas# : 1404437-62-2)ML-281 is a potent ans selective STK33 inhibitor (IC50 = 14 nM). ML281 showed low nan
• Maraviroc (Catalog# : 17022804, Cas# : 376348-65-1)Maraviroc (UK-427857; Selzentry; Celsentri) is a selective CCR5 antagonist (IC50= 6.4
• MMAE (Monomethyl auristatin E) (Catalog# : 17022403, Cas# : 474645-27-7)MMAE, also known as Monomethyl auristatin E, is a synthetic antineoplastic agent. Bec
• Monastrol (Catalog# : 17021322, Cas# : 329689-23-8)Monastrol is a cell-permeable small molecule inhibitor of kinesin-5(KIF11) which is
• MS049 (Catalog# : 17021313, Cas# : 1502816-23-0)MS049 is a potent and selective inhibitor of PRMT4 and PRMT6 with IC50s of 34 nM
• Miransertib(ARQ 092) (Catalog# : 17021301, Cas# : 1313883-00-9)ARQ 092 is a novel, orally bioavailable and selective AKT pathway inhibitor exhibit
• MT-DADMe-ImmA(MTDIA HCl) (Catalog# : 712101, Cas# : 1399840-35-7)Methylthio-DADMe-immucillin-A (MT-DADMe-ImmA) is an 86-pm inhibitor of human 5-methyl
• 7-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (Catalog# : 17011908, Cas# : 7752-54-7)7-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine 
• ML-7 (Catalog# : 17011107, Cas# : 110448-33-4)ML-7 is an inhibitor of smooth muscle myosin light chain kinase (MLCK) with a Ki 
• MX69 (Catalog# : 17011105, Cas# : 1005264-47-0)MX69 is a MDM2/XIAP inhibitor, used for cancer treatment. 
• MK-571 sodium salt (Catalog# : 16123055, Cas# : 115104-28-4)MK-571 is a selective, orally active CysLT1 receptor antagonist. It blocks the bindin
• Mizoribine (Catalog# : 16123053, Cas# : 50924-49-7)Mizoribine,Mizoribine (INN, trade name Bredinin) is an immunosuppressive drug. The co
• Mivebresib (Catalog# : 16123052, Cas# : 1445993-26-9)Mivebresib, also known as ABBV-075, is a potent BET inhibitor (bromodomain (BRD)-cont
• Mitoxantrone HCl (Catalog# : 16123051, Cas# : 65271-80-9)Mitoxantrone hydrochloride is the hydrochloride salt of an anthracenedione antibiotic
• Mirin (Catalog# : 16123049, Cas# : 1198097-97-0)Mirin is a Mre11-Rad50-Nbs1 (MRN)-ATM pathway inhibitor.
• Migalastat HCl (Catalog# : 16123048, Cas# : 75172-81-5)Migalastat HCl, also known as AT1001 or GR181413A, is a pharmacological chaperone tha
• MI-2 (MALT1 inhibitor) (Catalog# : 16123047, Cas# : 1047953-91-2)MI-2 is a MALT1 inhibitor (IC50 = 5.84 M). MI-2 binds directly to MALT1 and irreversi
• MG-101 (Catalog# : 16123046, Cas# : 110044-82-1)MG-101, also known as Calpain Inhibitor I and ALLN, is a calpain inhibitor (IC50 = 0.
• Mertansine (DM1) (Catalog# : 16123045, Cas# : 139504-50-0)Mertansine refers to the thiol-containing maytansinoid, DM1 (N2-deacetyl-N2-(3-mercap
• MC-976 (Catalog# : 16122832, Cas# : 129831-99-8)MC-976 is an Vitamin D3 derivative.
• Mafodotin (Catalog# : 16122831, Cas# : 863971-19-1)Mafodotin, also known as mc-MMAF and SGD-1269 or Maleimidocaproyl monomethylauristati
• Madrasin (Catalog# : 16122830, Cas# : 374913-63-0)Madrasin is a potent and cell penetrant splicing inhibitor that interferes with the e
• M2I-1 (Catalog# : 16122829, Cas# : 312271-03-7)M2I-1, also known as Mad2 Inhibitor-1, is Protein-Protein Interaction Inhibitor Targe
• MK571 (Catalog# : 161227105, Cas# : 115103-85-0)MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor)
• MPTP hydrochloride (Catalog# : 16122796, Cas# : 23007-85-4)MPTP hydrochloride is a dopaminergic neurotoxin and cause selective destruction of do
• ML323 (Catalog# : 16122790, Cas# : 1572414-83-5)ML323 is a highly potent and selective USP1-UAF1 inhibitor with IC50 of 76 nM.ML323 i
• ML390 (Catalog# : 16122749, Cas# : 2029049-79-2)ML390 is a human DHODH inhibitor that induces differentiation in acute myeloid leukem